Show Search Form
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Intensive Care: Drugs | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL10353 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what steps they are taking (1) to inform, and (2) to implement, the use of ready-to-use critical care medicines such as noradrenaline at trust-level; and what assessment they have made of the impact of these medicines on (a) safety levels, (b) drug error rates, and (c) nursing time saved. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2019/21 HL10353 | ||||||||||||||
type |
|
||||||||||||||
uin | HL10353 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Respiratory System: Health Services | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL10354 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what plans they have to ensure that funding is provided so that the respiratory commitments in the NHS Long Term Plan can be delivered in full. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2019/21 HL10354 | ||||||||||||||
type |
|
||||||||||||||
uin | HL10354 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Lung Diseases: Health Services | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL10355 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what steps they are taking to ensure that patients with lung conditions can access health services during the COVID-19 pandemic. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2019/21 HL10355 | ||||||||||||||
type |
|
||||||||||||||
uin | HL10355 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Lung Diseases: Rehabilitation | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL10356 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what steps they are taking to improve pulmonary rehabilitation services; and what funding has been allocated to any such work in the 2020/21 financial year. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2019/21 HL10356 | ||||||||||||||
type |
|
||||||||||||||
uin | HL10356 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Blood: Donors | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL10526 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what plans they have to lift the ban on the pharmaceutical use of pooled plasma from UK donors; and what assessment they have made of the impact of allowing the use of such plasma on national self-sufficiency in immunoglobulin and other plasma-derived medicinal products. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2019/21 HL10526 | ||||||||||||||
type |
|
||||||||||||||
uin | HL10526 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Blood: Donors | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL10527 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government when they estimate that the first plasma derived medicinal products sourced from UK plasma donors will become available for the treatment of NHS patients. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2019/21 HL10527 | ||||||||||||||
type |
|
||||||||||||||
uin | HL10527 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Medical Equipment: Import Duties | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL10622 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what assessment they have made of the level of tariff that would be introduced by the UK Global Tariff regime in the event of a no-deal Brexit on adhesive removal sprays for use with incontinence sheaths and stoma products; what assessment they have made of the impact of such a change on patients; and which other essential products for medical use will be subject to such tariffs. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2019/21 HL10622 | ||||||||||||||
type |
|
||||||||||||||
uin | HL10622 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Incontinence: Health Services | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL10623 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 10 November (HL8072), what progress they have made on the National Bladder and Bowel Health Project, including (1) who is serving on the panels, and (2) what the timescales are for the next phases of the project. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2019/21 HL10623 | ||||||||||||||
type |
|
||||||||||||||
uin | HL10623 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Skin Cancer: Medical Treatments | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL10624 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what assessment they have made of the number of (1) known or (2) suspected non-melanoma skin cancer patients in England who are waiting to be seen by a dermatologist; and how this compares to historical trends. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2019/21 HL10624 | ||||||||||||||
type |
|
||||||||||||||
uin | HL10624 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Skin Cancer | ||||||||||||||
house id | 2 | ||||||||||||||
identifier | HL10625 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 58 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask Her Majesty's Government what information they collect on the proportion of non-melanoma skin cancer patients who are diagnosed at early stages compared to the number of such patients who have been diagnosed at a late stage during the COVID-19 pandemic. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Lords Tabled Parliamentary Question 2019/21 HL10625 | ||||||||||||||
type |
|
||||||||||||||
uin | HL10625 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher |
|
||||||||||||||
tabling member |
|